BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mazal Plant Pharmaceuticals Inc. 



New York  New York    U.S.A.
Phone: Fax:


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Mazal Plant Pharmaceuticals Inc. Announces Filing of Provisional Patent for Cholesterol/HDL Investigational New Drug Formulation 6/12/2008 9:41:54 AM    More...
Mazal Plant Pharmaceuticals Inc. Announces Appointment of Dr. Michael Silver as New Scientific Director 5/30/2008 9:18:11 AM    More...
Mazal Plant Pharmaceuticals Inc. Announces Appointment of New CEO and New Corporate Counsel 5/21/2008 2:54:05 PM    More...
Mazal Plant Pharmaceuticals Inc. Announced Today The Appointment Of Mr. Stanley Fass As Interim President And Director 1/22/2007 10:27:15 AM    More...
Mazal Plant Pharmaceuticals Inc. Announces Appointment Of Richard Serbin As Head Of Business Advisory Board 10/12/2006 10:50:47 AM    More...
Mazal Plant Pharmaceuticals Inc. Release: Dr. Robert Siegel Appointed As Scientific Director 9/21/2006 3:17:40 PM    More...
Mazal Plant Pharmaceuticals Inc.'s Investigational New Drug Application Approved For Botanical HDL Cholesterol Elevating Drug, MAHDL 8/9/2006 12:17:47 PM    More...
Advanced Plant Pharmaceuticals, Inc. (APPI) And Subsidiary, Mazal Plant Pharmaceuticals Inc., File Investigational New Drug Application With FDA For Cholesterol-Lowering Drug 10/19/2005 5:12:50 PM    More...
Advanced Plant Pharmaceuticals, Inc. (APPI) Today Announced That It Had Sold Its 7 Million Shares In Mazal Plant Pharmaceuticals Inc. For 20 Million Shares In Akid Corporation 10/19/2005 5:11:57 PM    More...
Advanced Plant Pharmaceuticals, Inc.'s (APPI) Majority Owned Subsidiary, Mazal Plant Pharmaceuticals Inc., Receives Investigational New Drug Application Approval From The {2} For HDL/Cholesterol Improvement Drug 10/19/2005 5:09:54 PM    More...